UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016688
Receipt number R000019367
Scientific Title A study of the factor related to life-prolongation of patients with Duchenne muscular dystrophy
Date of disclosure of the study information 2015/03/03
Last modified on 2020/07/12 10:46:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of the factor related to life-prolongation of patients with Duchenne muscular dystrophy

Acronym

A study of the factor related to life-prolongation of DMD patients

Scientific Title

A study of the factor related to life-prolongation of patients with Duchenne muscular dystrophy

Scientific Title:Acronym

A study of the factor related to life-prolongation of DMD patients

Region

Japan


Condition

Condition

Duchenne muscular dystrophy

Classification by specialty

Neurology Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To clarify the factor that prolongs life expectancy of patients with Duchenne muscular dystrophy

Basic objectives2

Others

Basic objectives -Others

Time to death

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Time to death

Key secondary outcomes

Time at loss of ambulation


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Genetically confirmed as Duchenne muscular dystrophy
No limitation of disease stage.
No limitation of general condition.
No limitation of organ function (motor function, respiratory failure, cardiac failure, and dysphagia).
Patients with written informed consent.
In case of unable to make decision because of the age under 16 years or mental retardation, patient with written informed consent by parents or legal guardian.

Key exclusion criteria

Subject meets any of the following criteria is not enrolled in the study.
Not confirmed the diagnosis of DMD.
Subject considered to be an unsuitable candidate for the study by the Principal investigator or sub-investigator.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Toshio
Middle name
Last name Saito

Organization

National Hospital Organization Osaka Toneyama Medical Center

Division name

Child Neurology, Neurology

Zip code

5608552

Address

5-1-1 Toneyama, Toyonaka, Osaka, Japan

TEL

06-6853-2001

Email

saitot@toneyama.go.jp


Public contact

Name of contact person

1st name Toshio
Middle name
Last name Saito

Organization

National Hospital Organization Osaka Toneyama Medical Center

Division name

Clinical research center

Zip code

5608552

Address

5-1-1 Toneyama, Toyonaka, Osaka, Japan

TEL

06-6853-2001

Homepage URL


Email

saitot@toneyama.go.jp


Sponsor or person

Institute

National Hospital Organization

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

National Center of Neurology and Psychiatry

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization

Address

2-5-23 Higasigaoka, Meguroku, Tokyo

Tel

03-5712-5075

Email

kenkyu2004@hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構大阪刀根山医療センター(大阪),National Hospital Organization Osaka Toneyama Medical Center (Osaka)
国立病院機構東埼玉病院(埼玉),National Hospital Organization National Higashisaitama Hospital (Saitama)
国立病院機構あきた病院(秋田),National Hospital Organization National Akita Hospital (Akita)
国立病院機構仙台西多賀病院(宮城),National Hospital Organization National Sendai Nishitaga Hospital (Miyagi)
国立病院機構鈴鹿病院(三重),National Hospital Organization National Suzuka Hospital (Mie)
国立病院機構下志津病院(千葉),National Hospital Organization National Shimoshizu Hospital (Chiba)
国立病院機構長良医療センター(岐阜),National Hospital Organization Nagara Medical Center (Gifu)
国立病院機構長崎川棚医療センター(長崎),National Hospital Organization Nagasaki Kawatana Medical Center(Nagasaki)
国立病院機構大牟田病院(福岡), National Hospital Organization Omuta National Hospital (Fukuoka)


Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 09 Day

Date of IRB

2015 Year 01 Month 15 Day

Anticipated trial start date

2015 Year 03 Month 10 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2020 Year 03 Month 31 Day

Date analysis concluded



Other

Other related information

In this study, we evaluate the following factor;
Effects of artificial ventilation and cardioprotection therapy,
Influence of modifier,
Influence of mutation of Dystrophin gene,
Gain of motor function and life prognosis.


Management information

Registered date

2015 Year 03 Month 03 Day

Last modified on

2020 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019367


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name